| Makale Türü |
|
||
| Dergi Adı | BMC Pharmacology and Toxicology (Q2) | ||
| Dergi ISSN | 2050-6511 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | Türkçe | Basım Tarihi | 10-2025 |
| Cilt / Sayı / Sayfa | 26 / 173 / – | DOI | 10.1186/s40360-025-01014-x |
| Makale Linki | https://doi.org/10.1186/s40360-025-01014-x | ||
| Özet |
| Background Insulin resistance (IR) is a central pathological mechanism underlying metabolic syndrome and associated disorders, including type 2 diabetes and non-alcoholic fatty liver disease. This study investigated the therapeutic effects of darbepoetin alfa (DA), an erythropoietin analogue, in a dexamethasone (Dexa)-induced IR model, focusing on... |
| Anahtar Kelimeler |
| Apelin | Darbepoetin alfa | Dexamethasone | Galectin-3 | Insulin resistance | Liver fibrosis |
| Atıf Sayıları | |
| Scopus | 1 |
| Web of Science | 1 |
| Dergi Adı | BMC Pharmacology & Toxicology |
| Yayıncı | BioMed Central Ltd |
| Açık Erişim | Evet |
| E-ISSN | 2050-6511 |
| CiteScore | 4,7 |
| SJR | 0,814 |
| SNIP | 0,859 |